Cargando…
Incidence and Mortality of Prostate Cancer in Canada during 1992–2010
In Canada, prostate cancer is the most common reportable malignancy in men. We assessed the temporal trends of prostate cancer to gain insight into the geographic incidence and mortality trends of this disease. Three independent population-based cancer registries were used to retrospectively analyze...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985768/ https://www.ncbi.nlm.nih.gov/pubmed/33617514 http://dx.doi.org/10.3390/curroncol28010096 |
_version_ | 1783668318150852608 |
---|---|
author | Lagacé, François Ghazawi, Feras M. Le, Michelle Savin, Evgeny Zubarev, Andrei Powell, Mathieu Moreau, Linda Sasseville, Denis Popa, Ioana Litvinov, Ivan V. |
author_facet | Lagacé, François Ghazawi, Feras M. Le, Michelle Savin, Evgeny Zubarev, Andrei Powell, Mathieu Moreau, Linda Sasseville, Denis Popa, Ioana Litvinov, Ivan V. |
author_sort | Lagacé, François |
collection | PubMed |
description | In Canada, prostate cancer is the most common reportable malignancy in men. We assessed the temporal trends of prostate cancer to gain insight into the geographic incidence and mortality trends of this disease. Three independent population-based cancer registries were used to retrospectively analyze demographic data on Canadian men diagnosed with prostate cancer and men who died of prostate cancer between the years of 1992 and 2010. The incidence and mortality rates were calculated at the provincial, city, and forward sortation area (FSA) postal code levels by using population counts that were obtained from the Canadian Census of Population. The Canadian average incidence rate was 113.57 cases per 100,000 males. There has been an overall increasing trend in crude prostate cancer incidence between 1992 and 2010 with three peaks, in 1993, 2001, and 2007. However, age-adjusted incidence rates showed no significant increase over time. The national mortality rate was calculated to be 24.13 deaths per 100,000 males per year. A decrease was noted in crude and age-adjusted mortality rates between 1992 and 2010. Several provinces, cities, and FSAs had higher incidence/mortality rates than the national average. Several of the FSA postal codes with the highest incidence/mortality rates were adjacent to one another. Several Canadian regions of high incidence for prostate cancer have been identified through this study and temporal trends are consistent with those reported in the literature. These results will serve as a foundation for future studies that will seek to identify new regional risk factors and etiologic agents. |
format | Online Article Text |
id | pubmed-7985768 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79857682021-03-24 Incidence and Mortality of Prostate Cancer in Canada during 1992–2010 Lagacé, François Ghazawi, Feras M. Le, Michelle Savin, Evgeny Zubarev, Andrei Powell, Mathieu Moreau, Linda Sasseville, Denis Popa, Ioana Litvinov, Ivan V. Curr Oncol Article In Canada, prostate cancer is the most common reportable malignancy in men. We assessed the temporal trends of prostate cancer to gain insight into the geographic incidence and mortality trends of this disease. Three independent population-based cancer registries were used to retrospectively analyze demographic data on Canadian men diagnosed with prostate cancer and men who died of prostate cancer between the years of 1992 and 2010. The incidence and mortality rates were calculated at the provincial, city, and forward sortation area (FSA) postal code levels by using population counts that were obtained from the Canadian Census of Population. The Canadian average incidence rate was 113.57 cases per 100,000 males. There has been an overall increasing trend in crude prostate cancer incidence between 1992 and 2010 with three peaks, in 1993, 2001, and 2007. However, age-adjusted incidence rates showed no significant increase over time. The national mortality rate was calculated to be 24.13 deaths per 100,000 males per year. A decrease was noted in crude and age-adjusted mortality rates between 1992 and 2010. Several provinces, cities, and FSAs had higher incidence/mortality rates than the national average. Several of the FSA postal codes with the highest incidence/mortality rates were adjacent to one another. Several Canadian regions of high incidence for prostate cancer have been identified through this study and temporal trends are consistent with those reported in the literature. These results will serve as a foundation for future studies that will seek to identify new regional risk factors and etiologic agents. MDPI 2021-02-21 /pmc/articles/PMC7985768/ /pubmed/33617514 http://dx.doi.org/10.3390/curroncol28010096 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lagacé, François Ghazawi, Feras M. Le, Michelle Savin, Evgeny Zubarev, Andrei Powell, Mathieu Moreau, Linda Sasseville, Denis Popa, Ioana Litvinov, Ivan V. Incidence and Mortality of Prostate Cancer in Canada during 1992–2010 |
title | Incidence and Mortality of Prostate Cancer in Canada during 1992–2010 |
title_full | Incidence and Mortality of Prostate Cancer in Canada during 1992–2010 |
title_fullStr | Incidence and Mortality of Prostate Cancer in Canada during 1992–2010 |
title_full_unstemmed | Incidence and Mortality of Prostate Cancer in Canada during 1992–2010 |
title_short | Incidence and Mortality of Prostate Cancer in Canada during 1992–2010 |
title_sort | incidence and mortality of prostate cancer in canada during 1992–2010 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985768/ https://www.ncbi.nlm.nih.gov/pubmed/33617514 http://dx.doi.org/10.3390/curroncol28010096 |
work_keys_str_mv | AT lagacefrancois incidenceandmortalityofprostatecancerincanadaduring19922010 AT ghazawiferasm incidenceandmortalityofprostatecancerincanadaduring19922010 AT lemichelle incidenceandmortalityofprostatecancerincanadaduring19922010 AT savinevgeny incidenceandmortalityofprostatecancerincanadaduring19922010 AT zubarevandrei incidenceandmortalityofprostatecancerincanadaduring19922010 AT powellmathieu incidenceandmortalityofprostatecancerincanadaduring19922010 AT moreaulinda incidenceandmortalityofprostatecancerincanadaduring19922010 AT sassevilledenis incidenceandmortalityofprostatecancerincanadaduring19922010 AT popaioana incidenceandmortalityofprostatecancerincanadaduring19922010 AT litvinovivanv incidenceandmortalityofprostatecancerincanadaduring19922010 |